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Summary
We have generated an alloreactive proliferative T cell clone that only is stimulated by HLA-
DPw3+ antigen presenting cells (APC) that at the same time carry HLAA1. The T cell clone
is CD4+, and the proliferation is blocked by anti-DP monoclonal antibodies and not by
antibodies towards other class II or towards class I molecules. Family studies show that APC
with A1 and DPw3 on different haplotypes (trans) are able to stimulate the clone, and an HLA
recombinant family gives evidence that the class I-carrying part of the haplotype is necessary
for stimulation to occur. Stimulation is also observed with mixtures of APC expressing DPw3
and APC expressing Al, and likewise, DPw3+ APC become stimulatory when preincubated
with supernatants from Al-positive cells. Our studies suggest that major histocompatibility complex
(MHC) class I peptides presented by class II are allostimulatory and that APC can process MHC
molecules that presumably are presented as allele-specific peptides in the context of other MHC
molecules. We hypothesize that presentation of MHC peptides by MHC molecules constitutes
an important part of alloreactive phenomena in vivo and in vitro.
T
he MHC has a fundamental role for selection of the T
cell repertoire. The TCR recognizes probably a com-
plex consisting of an antigenic peptide and the MHC mole-
cule on the APC (1, 2). It is commonly agreed that the al-
loreaction is comparable with the antigen-specific response,
with the important modification that the peptide involved
is a selfpeptide (originating from the APC or the immediate
environment) presented by an allogeneicMHC molecule. Most
of the self peptides presented are probably nonpolymorphic
intra- or extracellular degradation products, but the minor
histocompatibility antigen systems are examples ofpresenta-
tion of polymorphic self peptides. Other examples of presenta-
tion ofpolymorphic peptides havebeen found in experiments
using transgenic mice or transfected cells where MHC pep-
tides may modulate the alloreactive response (3-5).
We have studied a humanalloreactiveT cell clone that prob-
ably recognizes a class I peptide in the context of a class II
molecule, and we hypothesize that presentation ofMHC pep-
tides by MHC molecules constitutes an important part of
alloreactivity in vivo and in vitro.
Materials and Methods
Generation ofT Cell Clones.
￿
PBMC from a responder "B" with
type HLAA2,25; B7,44; DR1,4; DQw1,3; DPw4 were cocultured
with an equal amount of irradiated (20 Gray=2,000 rad) PBMC
from a donor "DL" HLA-A1,28; B7,8; DRIA DQw1,3; DPw3
(at 106 cells/ml) in culture medium (RPMI 1640 supplemented
with 2 MM L-glutamine, 80 ng/ml streptomycin, 200 IU/ml peni-
cillin, and 10% inactivated pooled human serum). After 6 d of
culture in a humidified atmosphere at 37°C in 5% C02, the blasts
were purified over a 35-45% Percoll gradient and cloned in round-
bottomed microtiter plates (Nunc, Roskilde, Denmark) at 0.5
cells/well with 105 irradiated (100 Gray) lymphoblastoid cell line
(LCL) cells from the original stimulator in a total volume of 150
Al of culture medium. 3 d later, 10% of T cell growth factor-rich
supernatant (TCGF sup) was added. At day 12, the positive wells
were transferred to 2-ml well plates and restimulated with 10, ir-
radiated LCL from donor DL. The culture medium containing 10%
TCGF sup was changed three times a week, keeping the cell con-
centration <5 x 105 cells/ml. Every 12 d, the clones were restimu-
lated until sufficient amounts were obtained, whereupon the cloned
cells were cryopreserved in liquid nitrogen at the end ofrestimula-
tion cycles.
Proliferative Assays.
￿
The thawed clones were plated at 104 cells/
well in round-bottomed microtiter plates in the presence of 2.5 x
10' irradiated (100 Gray) LCL cells or 5 x 104 irradiated (20 Gray)
PBMC in a total of 150 Al of culture medium. After 48 h, the
cultures were labeled with 1 1Xi/well of ['H]thymidine; 16 h
later, the cells were harvested on glass fiber filter by a semiauto-
matic harvester (Skatron, Lierbyen, Norway), and the incorpora-
tion of labeled thymidine was quantitated by liquid scintillation
spectrometry. All cultures were done in triplicates and the median
counts per minute was used for evaluations.
MixturesofAPC.
￿
The irradiated (20 Gray) PBMC or (100 Gray)
LCL from two stimulators were mixedin various proportions, and
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cubated at various times at 37°C in 5% C02 in round-bottomed
microtiterplates in 100 jutculture medium before addition of 10'
clone cells in 50 gl ofculture medium. The proliferative assaywas
then carried as described above.
mAb InhibitionAssays.
￿
Four mAbs were used: L243 that reacts
with monomorphic determinants on DR molecules; TU22 (anti-
DQ); B7/21 (anti-DP); and W6/32 (anti-HLA-class I). The
blocking assay was carried out according to the 10th workshop
protocol with at least four different fivefold dilutions (6).
Results and Discussion
Of20 proliferative clones obtained from the priming (see
above), six couldbe expanded to reasonable number in order
to allow extended testings. The clone B/DL3, which is
CD4+, showed a peculiar restimulation pattern. In a panel
(7) of lymphoblastoid cell lines (LCL) from the 10th work-
shop, it appeared that all stimulatory APC carried HLAA1
in addition to the HLA-DPw3 antigen. This reactivity pat-
tern was confirmed in a local panel, and >60 different stimu-
lator cells have been tested repeatedly with similar results.
The reactivity of a subclone obtained by limiting dilution
was identical when tested on a small selected panel.
Testing in families showed that when A1 and DPw3 were
present on different haplotypes, only cells from individuals
that were at the same time Al and DPw3 stimulated the
clone. In the family shown in Fig. 1, one individual had a
recombination between HLAA and HLA-DR, and this
provided evidence that the HLA class I carrying part of the
haplotype was needed in order to give stimulation. The A3
and All antigens that are serologically crossreactive with Al
did not give any stimulation when present on DPw3+ cells.
Blocking experiments with mAbs showed that only anti-DP
antibodies were able to block the stimulation; anti-DR, anti-
DO, or anti-class I antibodies had little effect (Fig. 2).
Mixing experiments were performed with APC carrying
different combinations of class I antigens and DP antigens.
Mixtures of cells being DPw3 and cells being Al were in-
deed able to stimulate the clone and this in a dose-dependent
way (Fig. 3). Preliminary experiments showed that a 4-h prein-
cubation of the stimulating cells was optimal and that LCL
as well as PBMC could be used as APC in this and the other
experiments mentioned. A strong stimulation of the clone
was obtained when DPw3+ APC were preincubated with
supernatant from an Al' LCL and not with supernatant
from an Al- LCL (Table 1). This supernatant apparently
contains a sufficient amount of Al molecules, which after
processing by the DPw3+ APC, are presented as peptides on
DPw3 molecules. We have tested two peptides specific for
A1 (amino acids 65-84 and 143-158), but these peptides do
not stimulate our clone when preincubated with DPw3+
APC, and other peptides are under construction.
Several recent publications demonstrate that HLA class I
peptides can be recognized when presented on class I mole-
cules of another specificity (3) or that such peptides may in-
hibit alloreaction (4, 5). Likewise, viral peptides are able to
inhibit alloreaction (8). Our findings suggest that the pro-
cessing of class I peptides is a normally occurring in vitro
phenomenon in APC and that class II molecules are able to
present class I peptides.
Two earlier reports deal with CD4+ T cell clones having
a specificity correlating closely with a class I specificity, al-
Table 1.
￿
Proliferative Responses of the Clone B/DL3 against LCL Incubated with Culture Supernatants
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The test shows that the clone is stimulated by DPw3* APC when these are preincubated with supernatant from Al' LCL (A1 " sup).
Figures are median counts per minute of triplicate cultures, experimental value minus the value of stimulator cells alone. A zero indicates that
the experimental value is equal to or lower than that obtained with stimulator cells alone. The culture supernatants were from two LCLs,
positive (Al+ sup) and negative (Al - sup), respectively, for Al. The supernatant was collected after 3 d of culture at a concentration of LCL
of -106 cells/ml, filtered through a 0.22-pm filter, and 50 u1 was added to the stimulator cells. After an incubation at 37°C for 4 h, the
clone or control reagent was added and the proliferative test carried out as previously described. The HLA type of the stimulator cells:
STEINLIN: A1,B8,DR3,Dw3,DQw2,DPw3/4; L0081785: A3,24,B18,DR3,Dw3,DQw2,DPw3; SLE005: A2,B60,DRw13,Dw19,
DQw6,DPw3; BM21: Al,B41,DRwll,Dw5,DQw7,DPw2; BOLETH : A2,B62,DR4,Dw4,DQw8,DPw4. The control reagent is a polyclonal
T cell line raised against a pool of stimulators.
Responders
Stimulators
Workshop
no. Al* sup
B/DL3
Al - sup Medium Al* sup
Control reagent
Al - sup Medium
cpm
STEINLIN (A1,DPw3) 9057 10,982 8,634 11,445 38,325 39,895 31,430
SLE005 (DPw3) 9059 24,871 124 97 45,150 39,827 42,710
L0081785 (DPw3) 9018 12,209 444 555 42,338 40,730 43,636
BM21 (Al) 9043 0 0 0 45,597 41,339 45,247
BOLETH 9031 0 0 0 22,795 20,982 24,954Figure 1 .
￿
The proliferative responses of the clone B/DL3 against
the LCL from an informative family. The figures are median counts
per minute of triplicate cultures . Haplotypes in the family : a: HLA-
A2, B17, DRw6, DQwl, DPw3 ; b : HLA-Al, B17, DR7, DQw3,
DPw3 ; c: HLAAl, B8, DR3, DQw2, DPw2; d: HLAA9, B40,
DRw6, DQwl, DPw2; a"b : HLA-A2, B17, DR7, DQw3, DPw3 . A
recombination between the A and DR locus on the chromosome in-
herited from the father was observed in the child no. 6. The cells
from this child fail to stimulate the clone B/DL3 . The presence of
HLAAl and DPw3 at the same time coincides with a strong stimu-
lation, this combination can be in cis (nos . 1 and 7) or trans (nos. 3,
4, and 5) . A weak stimulation by the cells of the mother is probably
due to the presence of Al (see text),
though the reaction was blocked by anti-class II antibodies
and not by anti-class I antibodies (9, 10) . In those cases, no
restriction by class II was described, and this suggests that
the presentation of class I peptide was on a class Il molecule
showing little polymorphism, or alternatively, that the same
class I peptide could be presented by several class II mole-
cules. In the latter case, the T cell clone presumably recog-
nizes only the class I peptide and not the allodeterminants
of the class II molecule (11) . We have also, in some more
recent experiments, observed that A1+DPw3 - APC that
earlier did not stimulate could provoke a stimulation of the
clone B/DL3, while A1 -DPw3+ APC never have given
stimulation . In mice, isolated class I differences cause a strong
proliferation in primary mixed lymphocyte reaction(MLR),
and the reaction can be blocked by antibodies towards re-
sponder la while MLR towards class II differences are blocked
by antibodies towards la of the stimulator cells (12) .
The mixing experiments and the positive effect ofmedium
conditioned by Al-bearing cells suggest that class IHLA from
one cell can be presented as a peptide on class II HLA mole-
cules on another cell . This observation has possible implica-
tions for clinical transplantation, as APC from either donor
or recipient may present allogeneic HLA peptides and thus
initiate rejection processes .
389
Figure 2 .
￿
Proliferation of
clone B/DL3 towards a
A1,DPw3' LCL in presence of
mAbs towards HLA . Anti-
bodies used (6) : (" ) L243 that
reacts with monomorphic de-
terminants on DR molecules ;
(*) TU22 (anti-DQ; (A)
B7/21 (anti-DP); (/) W6/32
(anti-HLA-class 1) . The re-
sponse is percentage of re-
sponse without antibody .
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￿
Proliferative responses of clone B/DL3 against mixtures
of cells being Al and DPw3 . Each column represents the response of
the clone towards cells from the donors A and B in varying propor-
tions. The left-hand column represents the response of the clone to-
wards cells from A only, and the right-hand column towards cells
from B. Donor A : HLA-A1,29, B8,44, DR5,7, DPw2; donor B :
HLA-A24,29, B27,44, DR3w14, DPw2,3 . Cell mixing from other
panel donors or LCL from the workshop (>30 combinations tested)
gave identical results. When Al and DPw3 were present on the two
cell populations, a stimulation was seen .
T cell clones often display a reaction pattern that corre-
lates closely with a specificity defined by other methods (6),
and in such cases, the peptide presented byMHC is probably
a nonpolymorphic peptide originating from an autologous
protein that may be tissue specific (13) . Other clones have
reactions that are difficult to reconcile with a certain specificity
or epitope, even with knowledge of amino acid sequences
of the MHC molecule in question . Such reactions usually
segregate with HLA haplotypes in families but may also ap-
pear to depend on two different HLA haplotypes (14) . It is
tempting to speculate that such atypical results are due to
the presentation of a polymorphic MHC peptide, either class
I or II, by another MHC molecule.
Our hypothesis also explains some curious results on T
cell clones apparently stimulated by hybrid antigens (15, 16) .
One of these reports (15) deals with a clone that only was
stimulated by cells that were at the same timeDR2 andDR4 .
As the Met chain is nonpolymorphic, it was assumed that
the stimulatory molecule was a heterodimer consisting of a
DRa chain and a DQcx chain . Although the existence of
such molecules has been suggested in other cases bybiochem-
ical studies (17), the blocking studies performed by mAbs
were incompatible with such hybrid heterodimers . A more
plausible explanation is the presentation of a polymorphic
DQ (or DR) peptide by aDR molecule.
A recent report (18) describes T cell clones reactive with
a DR3 peptide presented by DPw3 . This indicates that the
same class II molecule (DPw3) has the possibility to bind
different HLA peptides . Examples of presentation of class IIpeptides by class I molecules have not yetbeen reported, but
it can be speculated, as recently suggested by Janeway (19),
that this might happen in T cells and constitute the molec-
ular basis for T cell suppressor networks.
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